Key takeaways:
- Affected person pay procedures are more likely to be impacted by a unstable financial local weather.
- Progressive, in-demand expertise might insulate ophthalmic segments from an unpredictable market.
PARK CITY, Utah — Segments that embody affected person pay or elective procedures are more likely to be impacted by a unstable financial market, based on a speaker at Eyecelerator.
Kirsten Harmon Ingenito, MBA, CEO of Market Scope, gave an replace on the ophthalmic market. She mentioned the best way monetary markets have responded to current authorities coverage modifications. Whereas the general ophthalmic market was value $48.8 billion in 2024, and there may be potential that some segments might see development sooner or later, Ingenito mentioned some elements of ophthalmology might battle in an unsure financial system.
“The 2 particular segments I wish to take a look at are refractive surgical procedure and IOLs as a result of there may be the affected person pay or elective element,” she mentioned. “These are those which might be most definitely to be affected by a unstable financial local weather.”
Ingenito mentioned two main unsure market climates additionally had an affect on refractive surgical procedure: the 2008 recession and the COVID-19 pandemic. She defined that the demand for refractive surgical procedure first began to see a decline late in 2007 earlier than taking a giant hit in 2008. There was not a lot restoration within the refractive market till about 2017, and it was impacted shortly afterward by the COVID-19 shutdowns.
“The years that we had been up above common had been marked by financial optimism, a booming housing market and low unemployment,” she mentioned. “These are all issues that have an effect on that 18-to-40-year-old demographic fairly considerably.”
For presbyopia-correcting IOLs, Ingenito mentioned she didn’t observe the identical decline famous in refractive surgical procedure. Sufferers on this section could possibly be extra insulated from financial volatility, she mentioned, and new merchandise additionally got here to market proper on the time of the financial downturn, like ReSTOR (Alcon) and Tecnis (Jonson & Johnson) earlier than the 2008 recession in addition to PanOptix (Alcon) and Vivity (Alcon) earlier than the COVID-19 pandemic.
“What that tells me is, though we’re taking place a little bit bit by way of [presbyopia-correcting] penetration, the opposite forms of fashions entering into are gaining some momentum,” Ingenito mentioned. “This market has numerous pull from the expertise that’s being launched, which provides me numerous optimism with all of you right here speaking about your new expertise and what that may do for the market.”
Sources/Disclosures
Collapse
Ingenito KH. Ophthalmic market view: The instances they’re a-changin’. Offered at: Eyecelerator; Might 2, 2025; Park Metropolis, Utah.
Disclosures:
Ingenito stories being CEO of Market Scope.
